Better Therapeutics

About:

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Website: https://www.bettertx.com

Twitter/X: better_tx

Top Investors: Hercules Capital, Farallon Capital Management, Sectoral Asset Management, Monashee Investment Management, RS Investments

Description:

Better Therapeutics discovers, develops, and commercializes prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases. They use clinically-validated, FDA-regulated software to change the behaviors that cause these diseases to aid in quality of life, reducing the need for medications, and lowering costs. Their products deliver digital behavioral therapy that integrates neuroscience, lifestyle medicine, and explainable AI into a physician-prescribed mobile medical app and uses patient-generated data to inform clinical decision-making and improve treatment outcomes. Their current product pipeline includes therapeutic candidates for the treatment of type 2 diabetes, hypertension, and dyslipidemia.

Total Funding Amount:

$151M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2015-04-01

Contact Email:

info(AT)bettertherapeutics.io

Founders:

David Perry, Kevin Appelbaum

Number of Employees:

51-100

Last Funding Date:

2024-01-23

IPO Status:

Public

© 2024 MyAiNote.com